Michael Greenwood

Feature Writer

B.Sc. Chemistry, M.Sc. Drug Design and Discovery

Michael graduated from the University of Salford with a PhD in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.

Articles from Michael

Novel SARS-CoV-2 vaccine utilizes recombinant spike protein with PIKA adjuvant

Novel SARS-CoV-2 vaccine utilizes recombinant spike protein with PIKA adjuvant

The primary aim of any vaccine is to stimulate immune functions and confer long-lasting protection. A paper recently uploaded to the preprint server bioRxiv by Tong et al. (17th Feb 2021) describes a novel vaccine utilizing PIKA adjuvant and recombinant spike proteins against COVID-19 disease that promises the generation of potent neutralization antibodies, which potentially support immune responses for years.

21 Feb 2021

Proteases modulate SARS-CoV-2 spike protein activation and deactivation

Proteases modulate SARS-CoV-2 spike protein activation and deactivation

A research paper recently uploaded to the preprint server bioRxiv by Platt et al. (17th Feb 2021) aimed to identify these enzymes by computational screening and molecular docking simulations, with cathepsins B, K, L, S, and V being highlighted as probable leads.

21 Feb 2021

Could measles virus vectors be used for a new COVID-19 vaccine?

Could measles virus vectors be used for a new COVID-19 vaccine?

A research team at the Institut Pasteur in France describes the successful development of such a vaccine utilizing a measles virus vector.

18 Feb 2021

Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine

Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine

High demand for the vaccines has raised questions as to whether it would be better in the long term to ensure that as much of the population as possible has received the first dose, i.e., vaccinate twice as many people with a lower rate of efficacy.

17 Feb 2021

How Could Nitric Oxide Treat Severe COVID-19?

How Could Nitric Oxide Treat Severe COVID-19?

Nitric oxide (NO) has the potential to be used to treat severe COVID-19 as it is a vasodilator, improving lung gas exchange and blood oxygenation.

16 Feb 2021

Nasal Disinfectants and their Application to COVID-19

Nasal Disinfectants and their Application to COVID-19

The use of nasal disinfectants on those who do or do not already suffer from COVID-19 may help to lessen contagiousness or act as a preventative.

15 Feb 2021

COVID-19 and Opioids

COVID-19 and Opioids

Opioids have been shown to affect the ordinary functioning of the immune system, and this may have significant implications for COVID-19 patients.

12 Feb 2021

The Rise of 3D Printing in the COVID-19 Pandemic

The Rise of 3D Printing in the COVID-19 Pandemic

3D printing has helped to ease the burden faced by healthcare providers in the ongoing COVID-19 pandemic in a variety of ways.

11 Feb 2021

The Importance of Pharmaceutical Packaging in Different Applications

The Importance of Pharmaceutical Packaging in Different Applications

Drugs may be distributed in a variety of primary and secondary pharmaceutical packaging, depending on the requirements of the drug itself and the intended user.

9 Feb 2021

What Standards Ensure the Quality of Pharmaceutical Packaging?

What Standards Ensure the Quality of Pharmaceutical Packaging?

The strict regulations that control the quality of drugs extend to the packaging of said drugs, with governing bodies around the world setting standards.

9 Feb 2021

Previous
1
...
20
21
22
23
24
25
26
...
31
Next

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.